| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 63,533 | 58,568 | 50,976 | 53,684 | | Cost of Revenue | 28,840 | 29,786 | 23,460 | 24,947 | | | Gross Profit | 34,693 | 28,782 | 27,516 | 28,737 | | | Operating Expenses | | Research Development | 10,842 | 8,792 | 7,215 | 6,755 | | Selling General and Administrative | 13,654 | 13,581 | 14,103 | 14,222 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,197 | 6,409 | 6,198 | 7,760 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 527 | 1,756 | 772 | (5,084) | | Earnings Before Interest And Taxes | 10,724 | 8,165 | 6,970 | 2,676 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 10,724 | 8,165 | 6,970 | 2,676 | | Income Tax Expense | 1,646 | 962 | 1,185 | 476 | | Minority Interest | (6) |
-
|
-
| 11 | | | | Net Income From Continuing Ops | 9,078 | 7,203 | 5,785 | 2,211 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,072 | 7,203 | 5,785 | 2,211 | | Preferred Stock And Other Adjustments | (7) | 2 | 5 |
-
| | | Net Income Applicable To Common Shares | $9,065 | $7,205 | $5,790 | $2,211 |
|
0.02% Nasdaq 
0.33%
Income Statement
